The Medical Advisor

You probably know some of the most common causes of cancer, thanks to the efforts of public health campaigns. In 1964, U.S. Surgeon General Luther Terry issued the first report on smoking and health, which concluded that smoking caused lung and throat cancer as well as what’s now known as COPD. After that, programs to stop smoking are estimated to have saved about 3.4 million people from dying of lung cancer . Similarly, then-Surgeon General Vivek H. Murthy issued an advisory earlier this year on alcohol ’s link to certain types of cancer . Credit: Grok 3 There’s clear evidence that smoking and drinking alcohol can increase the risk of cancer, based on extensive data over decades. But you may occasionally see headlines linking other behaviors to cancer, such as getting tattoos and even drinking hot liquids. Keep in mind that none of these factors has evidence on par with risks like drinking alcohol or smoking. That said, here are five surprising things that have been associated with ...

Dr. Dale Bredesen, a neurologist specializing in the treatment of Alzheimer’s published a paper (1) in 2014, demonstrating the power of lifestyle choices for the prevention and treatment of this tragic condition. By leveraging 36 healthy lifestyle parameters, he was able to reverse Alzheimer’s in nine out of 10 patients. This is part 2 of the ReCODE protocol series. For part 1, visit " RECODE Protocol for Alzheimer's: Dr Dale Bredesen ". Dr Dale Bradesen latest book “The Ageless Brain” @Amazon Dementia vs. Alzheimer’s Disease: What is the Difference?   Randomized Trial Launch Aims to Track and Reverse Cognitive Decline For starters, his team has published another proof-of-concept paper and is launching a randomized, controlled trial at six sites — Hollywood, Florida; Nashville, Tennessee; Cleveland, Ohio; and Sacramento, Oakland and San Francisco in California. • The trial will assess biological aging, brain aging and e...

Mike Ridgway of Tennessee treated his early lymphoma with two shoeboxes of medications from India. Within eleven months, his three PET scans went from ominous to better to normal. A retired software programmer, Ridgway took long-established, off-patent drugs that are surely not on a typical oncologist’s radar: ivermectin, fenbendazole (a veterinary drug), and colchicine. They cost $400 for six months of treatment. Standard pharmaceuticals for early lymphoma, by contrast,  cost  an average $12,396 a year in the United States. Cancer medications, no surprise, are Pharma’s  biggest  money-maker, with $160 billion in sales annually, or 20 percent of world drug revenues. Ridgway, who is sixty-five years old, represents a small share of cancer patients who choose alternative care in part because they mistrust profit-driven oncology and dislike the chemo drawbacks. The drugs they take—under the supervision of a physician and sometimes with traditional therapies—are support...